Forced Desynchrony for Cardiovascular Risk

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cardiovascular Risk+1 MoreForced Desynchrony - Behavioral
Eligibility
40 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help determine if different therapies for hypertension are effective for black adults based on the root cause of their hypertension.

Eligible Conditions
  • Cardiovascular Risk
  • High Blood Pressure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 9 Secondary · Reporting Duration: 7-day lab stay

2 day ambulatory period
24-hr ambulatory blood pressure
7-day lab stay
Blood pressure
Heart rate variability
beat-by-beat blood pressure
flow mediated dilation
saliva cortisol
saliva melatonin
venous aldosterone
venous endocannabinoids
venous epinephrine
venous norepinephrine

Trial Safety

Trial Design

1 Treatment Group

Forced Desynchrony
1 of 1

Experimental Treatment

52 Total Participants · 1 Treatment Group

Primary Treatment: Forced Desynchrony · No Placebo Group · N/A

Forced Desynchrony
Behavioral
Experimental Group · 1 Intervention: Forced Desynchrony · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Forced Desynchrony
2014
N/A
~40

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 7-day lab stay

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
893 Previous Clinical Trials
6,829,425 Total Patients Enrolled
6 Trials studying Cardiovascular Risk
1,642 Patients Enrolled for Cardiovascular Risk
Steven A Shea, PhDPrincipal InvestigatorOre
3 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Cardiovascular Risk
28 Patients Enrolled for Cardiovascular Risk

Eligibility Criteria

Age 40 - 60 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are free of all prescription and non-prescription drugs.